High intensity interval training is superior to moderate intensity continuous training improves insulin resistance probably via increasing circulating spexin

Document Type : Research Paper

Authors

1 Department of Exercise Physiology, Faculty of Sports Sciences, Alzahra University, Tehran, Iran

2 Department of Sports Science, School of Literature and Humanities, Ilam University, Ilam, Iran.

3 4. PhD of Exercise Physiology, Ilam Education Office, Ilam, Iran

Abstract

Objectives: Obesity by decreasing adipokines involve in insulin resistance such as spexin is associated with insulin resistance. The aim of this study was to evaluate and compare the effects of high intensity interval training (HIIT) and aerobic training on serum levels of spexin and insulin resistance in overweight women.
Methods & Materials: Thirty overweight women (BMI> 25 kg/m2) voluntarily participated in this study. Subject were divided into three groups; HIIT, aerobic training and control groups. HIIT training was included 4 ×4-min at 85-95% maximal heart rate interspersed with 3-min active recovery periods. Aerobic training was included 37 minutes of moderate intensity. Both protocols were matched for calorie expenditure. Body weight and blood samples were measured before and 48 hours after last training session. Insulin, glucose, insulin resistance index (HOMA-IR) and spexin were evaluated. Data were analyzed by ANCOVA and paired t test.
Results: The results showed that HIIT was associated with higher serum spexin levels compared to the control group (P=0.001). Furthermore, both training protocols decreased insulin, glucose and HOMA-IR in comparison with the control group (P=0.0001). However, there were no significant differences between two exercise training groups in insulin, glucose, insulin resistance and spexin (P> 0.05).
Conclusion: The findings suggest that HIIT by increasing serum spexin partly improves insulin resistance in overweight women.

Keywords

Main Subjects

References

  1. Wong MC, Huang J, Wang J, Chan PS, Lok V, Chen X, et al. Global, regional and time-trend prevalence of central obesity: A systematic review and meta-analysis of 13.2 million subjects. European journal of epidemiology. 2020;35:673-83.
  2. Santosa S, Demonty I, Lichtenstein AH, Cianflone K, Jones PJ. An investigation of hormone and lipid associations after weight loss in women. Journal of the American College of Nutrition. 2007;26(3):250-8.
  3. Porzionato A, Rucinski M, Macchi V, Stecco C, Malendowicz LK, De Caro R. Spexin expression in normal rat tissues. Journal of Histochemistry & Cytochemistry. 2010;58(9):825-37.
  4. Kolodziejski PA, Pruszynska-Oszmalek E, Micker M, Skrzypski M, Wojciechowicz T, Szwarckopf P, et al. Spexin: a novel regulator of adipogenesis and fat tissue metabolism. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2018;1863(10):1228-36.
  5. Walewski JL, Ge F, Lobdell IV H, Levin N, Schwartz GJ, Vasselli JR, et al. Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet‐induced obesity. Obesity. 2014;22(7):1643-52.
  6. Kumar S, Hossain M, Javed A, Kullo I, Balagopal PB. Relationship of circulating spexin with markers of cardiovascular disease: a pilot study in adolescents with obesity. Pediatric obesity. 2018;13(6):374-80.
  7. Lin C-y, Huang T, Zhao L, Zhong LL, Lam WC, Fan B-m, et al. Circulating spexin levels negatively correlate with age, BMI, fasting glucose, and triglycerides in healthy adult women. Journal of the Endocrine Society. 2018;2(5):409-19.
  8. Gu L, Ma Y, Gu M, Zhang Y, Yan S, Li N, et al. Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes. Peptides. 2015;71:232-9.
  9. Sassek M, Kolodziejski PA, Strowski MZ, Nogowski L, Nowak KW, Mackowiak P. Spexin modulates functions of rat endocrine pancreatic cells. Pancreas. 2018;47(7):904-9.
  10. Mohammadi A, Bijeh N, Moazzami M, khodaei K, Rahimi N. Effect of exercise training on spexin level, appetite, lipid accumulation product, visceral adiposity index, and body composition in adults with type 2 diabetes. Biological Research For Nursing. 2022;24(2):152-62.
  11. Leciejewska N, Pruszyńska-Oszmałek E, Mielnik K, Głowacki M, Lehmann TP, Sassek M, et al. Spexin Promotes the Proliferation and Differentiation of C2C12 Cells In Vitro—The Effect of Exercise on SPX and SPX Receptor Expression in Skeletal Muscle In Vivo. Genes. 2021;13(1):81.
  12. Ross LM, Porter RR, Durstine JL. High-intensity interval training (HIIT) for patients with chronic diseases. Journal of sport and health science. 2016;5(2):139-44.
  13. Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectrum. 2015;28(1):39-44.
  14. Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes care. 2013;36(2):228-36.
  15. Kolahdouzi S, Talebi-Garakani E, Hamidian G, Safarzade A. Exercise training prevents high-fat diet-induced adipose tissue remodeling by promoting capillary density and macrophage Life sciences. 2019;220:32-43.
  16. Nazari, Somayeh, Isanejad A, Gharib, Behroz, Ghanbari Motlagh A, Samadi A. Effect of Interval and Continuous Training on Functional Capacity and Body Composition in Breast Cancer Survivors. Journal of Applied Health Studies in Sport Physiology. 2020;7(1):1-8.
  17. Chen T, Wang F, Chu Z, Sun L, Lv H, Zhou W, et al. Circulating spexin decreased and negatively correlated with systemic insulin sensitivity and pancreatic β cell function in obese children. Annals of Nutrition and Metabolism. 2019;74(2):125-31.
  18. Khadir A, Kavalakatt S, Madhu D, Devarajan S, Abubaker J, Al-Mulla F, et al. Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes. Scientific reports. 2020;10(1):1-11.
  19. Al-Daghri NM, Wani K, Yakout SM, Al-Hazmi H, Amer OE, Hussain SD, et al. Favorable changes in fasting glucose in a 6-month self-monitored lifestyle modification programme inversely affects spexin levels in females with prediabetes. Scientific reports. 2019;9(1):1-9.
  20. Ceylan Hİ, Saygın Ö, Özel Türkcü Ü. Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men. Chronobiology International. 2020;37(8):1252-68.
  21. Kumar S, Hossain J, Nader N, Aguirre R, Sriram S, Balagopal PB. Decreased circulating levels of spexin in obese children. The Journal of Clinical Endocrinology & Metabolism. 2016;101(7):2931-6.
  22. Jasmine FG, Walewski J, Anglade D, Berk P, editors. Regulation of hepatocellular fatty acid uptake in mouse models of fatty liver disease with and without functional leptin signaling: roles of NfKB and SREBP-1C and the effects of spexin. Seminars in liver disease; 2016: Thieme Medical Publishers.
  23. Lin C-y, Zhao L, Huang T, Lu L, Khan M, Liu J, et al. Spexin acts as novel regulator for bile acid synthesis. Frontiers in physiology. 2018;9:378.
  24. Pruszynska-Oszmalek E, Sassek M, Szczepankiewicz D, Nowak KW, Kolodziejski PA. Short-term administration of spexin in rats reduces obesity by affecting lipolysis and lipogenesis: An in vivo and in vitro study. General and Comparative Endocrinology. 2020;299:113615.
  25. Wong MK, Sze KH, Chen T, Cho CK, Law HC, Chu IK, et al. Goldfish spexin: solution structure and novel function as a satiety factor in feeding control. American Journal of Physiology-Endocrinology and Metabolism. 2013;305(3):E348-E66.
  26. Kołodziejski P, Pruszyńska-Oszmałek E, Korek E, Sassek M, Szczepankiewicz D, Kaczmarek P, et Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women. Physiological research. 2018;67(1):45-56.
  27. Reyes-Alcaraz A, Lee Y-N, Son GH, Kim NH, Kim D-K, Yun S, et al. Development of spexin-based human galanin receptor type II-specific agonists with increased stability in serum and anxiolytic effect in mice. Scientific reports. 2016;6(1):1-10.
  28. Guo L, Shi M, Zhang L, Li G, Zhang L, Shao H, et al. Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats. General and comparative endocrinology. 2011;173(1):159-63.
  29. Gambaro SE, Zubiría MG, Giordano AP, Portales AE, Alzamendi A, Rumbo M, et al. Spexin improves adipose tissue inflammation and macrophage recruitment in obese mice. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2020;1865(7):158700.
  30. Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Archives of physiology and biochemistry. 2008;114(3):183-94.
  31. Li M, Han Z, Bei W, Rong X, Guo J, Hu X. Oleanolic acid attenuates insulin resistance via NF-κB to regulate the IRS1-GLUT4 pathway in HepG2 cells. Evidence-Based Complementary and Alternative Medicine. 2015;2015.
  32. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852-71.
  33. Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11:S307-S9.
  34. Hennessy EJ, Parker AE, O'neill LA. Targeting Toll-like receptors: emerging therapeutics? Nature reviews Drug discovery. 2010;9(4):293-307.
  35. Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. The Journal of Clinical Endocrinology & Metabolism. 2014;99(1):39-48.
Sport Physiology
Volume 15, Issue 57
April 2023
Pages 113-130

Files

History

  • Receive Date: 27 October 2022
  • Revise Date: 21 August 2023
  • Accept Date: 27 August 2023

Share

How to cite

Statistics